Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of S-8184 in Second Line Ovarian Cancer
NCT00034151Phase 2Completed
- Sponsor
- Achieve Life Sciences
- Start
- Mar 2002
- Primary completion
- Sep 2007
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of paclitaxel in ovarian cancer, primary peritoneal carcinoma (PPC), sponsored by Achieve Life Sciences. Started Mar 2002; status: completed.
02
Drugs
paclitaxel
03
Conditions
ovarian cancerprimary peritoneal carcinoma (PPC)
Beyond the preview
Go deeper on NCT00034151.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00034151.